Effects of three oral dosages of S 44121 on cardiac arrhythmia during exercise testing in patients with catecholaminergic polymorphic ventricular tachycardia type 1. A 3-day, single-blind, international multicentre study.
Phase of Trial: Phase II
Latest Information Update: 09 Oct 2013
At a glance
- Drugs Aladorian (Primary)
- Indications Ventricular tachycardia
- Focus Therapeutic Use
- 14 Jun 2011 New trial record